Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure

Urinary bladder cancer (UBC) is the most common malignancy of the urinary tract in humans, with an estimated global prevalence of 1.1 million cases over 5 years. Because of its high rates of recurrence and resistance to chemotherapy, UBC is one of the most expensive cancers to treat, resulting in si...

Full description

Bibliographic Details
Main Authors: Sarah Minkler, Fabrice Lucien, Michael J. Kimber, Dipak K. Sahoo, Agnes Bourgois-Mochel, Margaret Musser, Chad Johannes, Igor Frank, John Cheville, Karin Allenspach, Jonathan P. Mochel
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/3/422
id doaj-0dda59f830d840f6aebd71e90b828fe9
record_format Article
spelling doaj-0dda59f830d840f6aebd71e90b828fe92021-01-24T00:01:16ZengMDPI AGCancers2072-66942021-01-011342242210.3390/cancers13030422Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s TreasureSarah Minkler0Fabrice Lucien1Michael J. Kimber2Dipak K. Sahoo3Agnes Bourgois-Mochel4Margaret Musser5Chad Johannes6Igor Frank7John Cheville8Karin Allenspach9Jonathan P. Mochel10SMART Translational Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Urology, Mayo Clinic, Rochester, MN 55902, USADepartment of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USASMART Translational Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USADepartment of Urology, Mayo Clinic, Rochester, MN 55902, USADepartment of Urology, Mayo Clinic, Rochester, MN 55902, USASMART Translational Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USASMART Translational Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USAUrinary bladder cancer (UBC) is the most common malignancy of the urinary tract in humans, with an estimated global prevalence of 1.1 million cases over 5 years. Because of its high rates of recurrence and resistance to chemotherapy, UBC is one of the most expensive cancers to treat, resulting in significant health care costs. The development of innovative molecular and cellular tools is necessary to refine patient stratification and help predict response to treatment. Urine is an underused resource of biological components shed from bladder tumors, such as exfoliated cells and extracellular vesicles, that could serve as molecular fingerprints and provide valuable biological insights into tumor phenotype and mechanisms of resistance to chemotherapy. Additionally, characterization of urine-derived extracellular vesicles and cells could be used as reliable biomarkers for prediction of response to neoadjuvant therapy.https://www.mdpi.com/2072-6694/13/3/422bladder cancerorganoidsexosomesprecision medicineone health
collection DOAJ
language English
format Article
sources DOAJ
author Sarah Minkler
Fabrice Lucien
Michael J. Kimber
Dipak K. Sahoo
Agnes Bourgois-Mochel
Margaret Musser
Chad Johannes
Igor Frank
John Cheville
Karin Allenspach
Jonathan P. Mochel
spellingShingle Sarah Minkler
Fabrice Lucien
Michael J. Kimber
Dipak K. Sahoo
Agnes Bourgois-Mochel
Margaret Musser
Chad Johannes
Igor Frank
John Cheville
Karin Allenspach
Jonathan P. Mochel
Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
Cancers
bladder cancer
organoids
exosomes
precision medicine
one health
author_facet Sarah Minkler
Fabrice Lucien
Michael J. Kimber
Dipak K. Sahoo
Agnes Bourgois-Mochel
Margaret Musser
Chad Johannes
Igor Frank
John Cheville
Karin Allenspach
Jonathan P. Mochel
author_sort Sarah Minkler
title Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
title_short Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
title_full Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
title_fullStr Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
title_full_unstemmed Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
title_sort emerging roles of urine-derived components for the management of bladder cancer: one man’s trash is another man’s treasure
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2021-01-01
description Urinary bladder cancer (UBC) is the most common malignancy of the urinary tract in humans, with an estimated global prevalence of 1.1 million cases over 5 years. Because of its high rates of recurrence and resistance to chemotherapy, UBC is one of the most expensive cancers to treat, resulting in significant health care costs. The development of innovative molecular and cellular tools is necessary to refine patient stratification and help predict response to treatment. Urine is an underused resource of biological components shed from bladder tumors, such as exfoliated cells and extracellular vesicles, that could serve as molecular fingerprints and provide valuable biological insights into tumor phenotype and mechanisms of resistance to chemotherapy. Additionally, characterization of urine-derived extracellular vesicles and cells could be used as reliable biomarkers for prediction of response to neoadjuvant therapy.
topic bladder cancer
organoids
exosomes
precision medicine
one health
url https://www.mdpi.com/2072-6694/13/3/422
work_keys_str_mv AT sarahminkler emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT fabricelucien emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT michaeljkimber emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT dipakksahoo emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT agnesbourgoismochel emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT margaretmusser emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT chadjohannes emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT igorfrank emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT johncheville emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT karinallenspach emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
AT jonathanpmochel emergingrolesofurinederivedcomponentsforthemanagementofbladdercanceronemanstrashisanothermanstreasure
_version_ 1724326939086290944